Nuvectis Pharma Inc (NVCT)
8.14
+1.38
(+20.41%)
USD |
NASDAQ |
May 03, 16:00
8.145
0.00 (0.00%)
After-Hours: 20:00
Nuvectis Pharma 1 Year Total Returns (Daily): -43.20% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -43.20% |
May 02, 2024 | -53.09% |
May 01, 2024 | -56.19% |
April 30, 2024 | -58.92% |
April 29, 2024 | -56.89% |
April 26, 2024 | -56.20% |
April 25, 2024 | -55.41% |
April 24, 2024 | -53.21% |
April 23, 2024 | -52.52% |
April 22, 2024 | -48.85% |
April 19, 2024 | -53.38% |
April 18, 2024 | -54.16% |
April 17, 2024 | -53.54% |
April 16, 2024 | -52.65% |
April 15, 2024 | -56.51% |
April 12, 2024 | -51.59% |
April 11, 2024 | -47.30% |
April 10, 2024 | -42.65% |
April 09, 2024 | -40.85% |
April 08, 2024 | -39.92% |
April 05, 2024 | -38.35% |
April 04, 2024 | -42.42% |
April 03, 2024 | -37.41% |
April 02, 2024 | -39.44% |
April 01, 2024 | -39.51% |
Date | Value |
---|---|
March 28, 2024 | -31.67% |
March 27, 2024 | -30.38% |
March 26, 2024 | -29.82% |
March 25, 2024 | -24.37% |
March 22, 2024 | -26.49% |
March 21, 2024 | -26.78% |
March 20, 2024 | -29.72% |
March 19, 2024 | -26.61% |
March 18, 2024 | -12.55% |
March 15, 2024 | 0.36% |
March 14, 2024 | -11.51% |
March 13, 2024 | -3.02% |
March 12, 2024 | -8.28% |
March 11, 2024 | -5.78% |
March 08, 2024 | -7.23% |
March 07, 2024 | -10.41% |
March 06, 2024 | -17.31% |
March 05, 2024 | -14.86% |
March 04, 2024 | -14.02% |
March 01, 2024 | -7.12% |
February 29, 2024 | -13.65% |
February 28, 2024 | -14.00% |
February 27, 2024 | -11.18% |
February 26, 2024 | -11.21% |
February 23, 2024 | -27.48% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-58.92%
Minimum
Apr 30 2024
235.1%
Maximum
Feb 06 2023
25.83%
Average
28.06%
Median
Jul 19 2023
1 Year Total Returns (Daily) Benchmarks
Schrodinger Inc | -18.76% |
CEL-SCI Corp | -27.23% |
AIM ImmunoTech Inc | -15.65% |
IGC Pharma Inc | 53.98% |
NovaBay Pharmaceuticals Inc | -90.79% |